World Pharma News

FEBRUARY 26, 2024

Despite treatments such as surgery, radiation therapy and chemotherapy, only about a quarter of all people with the disease will live more than five years after diagnosis, and lung cancer kills more than 1.8 Lung cancer is not the most common form of cancer, but it is by far the deadliest.

Chemotherapy 82

Chemotherapy 82

Pharmacy Times

APRIL 19, 2024

Individuals treated with chemotherapy following a breast cancer diagnosis were more at risk of developing second primary lung cancer.

Chemotherapy 47

Chemotherapy 47

Express Pharma

SEPTEMBER 10, 2023

Results presented from the Phase III IMpower133 study and extension trial IMbrella A, show Roche’s Tecentriq (atezolizumab), in combination with chemotherapy, demonstrates a potential long-term overall survival (OS) benefit as first-line treatment for extensive-stage small cell lung cancer (ES-SCLC). 0.91; p=0.0069). JTO Clin Res Rep.

Chemotherapy 109

Chemotherapy 109

epicur

MARCH 12, 2024

Epicur Pharma’s Advisory Council member Ann Donoghue, DVM, MS shares her personal perspective on the important relationship between veterinary oncology and compounded medications used in chemotherapy treatments. Many of the presentations discussed the chemotherapies available to treat dogs.

Compounding 52

Compounding Chemotherapy Compounding Pharmacies Labelling 52

Pharmaceutical Technology

MARCH 20, 2024

GlobalData tracks 8 drugs in development for Chemotherapy-Induced Diarrhea (CID) by seven companies/universities/institutes. The top development phase for Chemotherapy-Induced Diarrhea (CID) is preclinical, with two drugs in that stage.

Chemotherapy 40

Chemotherapy 40

European Pharmaceutical Review

APRIL 7, 2023

A new, sustained-release chemotherapy delivery device inserted into the bladder, facilitated tumour response, a study has reported. The intravesical device, TAR-200, provides continuous, low-dose, local delivery of gemcitabine chemotherapy. All patients had transurethral resection of bladder tumour (TURBT) to remove visible tumour.

Chemotherapy 85

Chemotherapy Mayo Clinic 85

PharmExec

MARCH 7, 2024

Opdivo (nivolumab) plus cisplatin and gemcitabine was found to improve overall survival and progression-free survival compared with chemotherapy alone in patients with unresectable or metastatic urothelial carcinoma.

Chemotherapy 52

Chemotherapy 52

Pharmaceutical Commerce

FEBRUARY 19, 2024

Tagrisso (osimertinib) approved for use in combination with platinum-based chemotherapy in adults with locally advanced or metastatic epidermal growth factor receptor-mutated non-small cell lung cancer harboring EGFR exon 19 deletions or exon 21 L858R mutations.

Chemotherapy 52

Chemotherapy 52

Pharmafile

MARCH 3, 2023

Scientists from the Institute of Cancer Research London, Imperial College London and the Netherlands Cancer Institute have researched a gene test which can select which advanced bowel cancer patients will respond the best to chemotherapy. read more

Chemotherapy 83

Chemotherapy Communication 83

PharmExec

NOVEMBER 17, 2023

Merck's pembrolizumab (Keytruda) plus fluoropyrimidine- and platinum-containing chemotherapy approved for the first-line treatment of patients with locally advanced unresectable or metastatic, HER2-negative GEJ adenocarcinoma.

Chemotherapy 52

Chemotherapy 52

PharmExec

NOVEMBER 9, 2023

Fruquintinib (Fruzaqla) is the first novel chemotherapy-free treatment option approved for metastatic colorectal cancer in more than a decade.

Chemotherapy 59

Chemotherapy 59

LifeProNow

APRIL 25, 2023

The trial met its primary endpoint of investigator-assessed progression-free survival (PFS), showing a statistically significant and clinically meaningful benefit versus placebo plus chemotherapy in patients treated with dostarlimab plus carboplatin-paclitaxel in the dMMR/MSI-H population.

Chemotherapy 130

Chemotherapy 130

STAT

JANUARY 22, 2024

Gilead Sciences said Monday that Trodelvy, its “smart-bomb” medicine that combines an antibody with chemotherapy, did not significantly extend the lives of patients with metastatic non-small cell lung cancer when given after a first treatment failed. Continue to STAT+ to read the full story…

Chemotherapy 308

Chemotherapy 308

Pharmafile

NOVEMBER 28, 2022

South Korean biotech firm Hyundai Bioscience’s innovative chemotherapy drug may be able to complete cancer treatments in two doses. The new anticancer drug, Polytaxel, is set to enter a clinical trial on pancreatic cancer being held in Australia. read more.

Chemotherapy 78

Chemotherapy 78

Pharmaceutical Commerce

NOVEMBER 17, 2023

Pembrolizumab (Keytruda) plus fluoropyrimidine- and platinum-containing chemotherapy for locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction cancer approved by FDA after being found to lower the risk of metastasis or death.

Chemotherapy 52

Chemotherapy 52

Pharmacy Times

MARCH 14, 2024

Results from the phase 3 RATIONALE 302 trial showed tislelizumab-jsgr prolonged survival compared to chemotherapy in patients who received prior systemic treatment.

Chemotherapy 49

Chemotherapy 49

STAT

OCTOBER 21, 2023

MADRID — A Roche drug lowered the risk of recurrence or death by 76% versus chemotherapy for patients with a type of early non-small cell lung cancer, according to data from a Phase 3 trial presented Saturday. The standard treatment after surgery for these patients is chemotherapy.

Chemotherapy 324

Chemotherapy Drug Development 324

Pharmaceutical Technology

DECEMBER 4, 2023

The Chemotherapy Induced Nausea and Vomiting drugs in development market research report provides comprehensive information on the therapeutics under development…

Chemotherapy 40

Chemotherapy 40

pharmaphorum

FEBRUARY 10, 2021

The PHERGain II study’s goal is to find an effective therapeutic strategy that can reduce the use of chemotherapy and improve the quality of life of patients without compromising the clinical effectiveness of their treatment.

Chemotherapy 90

Chemotherapy Hospitals 90

The Guardian - Pharmaceutical Industry

JULY 7, 2023

Three health regulators have launched inquiries into the incident, according to people familiar with the matter.

Chemotherapy 76

Chemotherapy 76

Pharmafile

APRIL 25, 2023

GSK has announced that the European Medicines Agency (EMA) has validated the company’s Type II Variation for a new indication for Jemperli (dostarlimab) alongside chemotherapy for the treatment of adult patients with mismatch repair deficient (dMMR)/microsatellite instability-high (MSI-H) primary advanced or recurrent endometrial cancer.

Chemotherapy 59

Chemotherapy Communication 59

World Pharma News

MARCH 3, 2023

Cancer cells have an innate randomness in their ability to respond to chemotherapy, which is another tool in their arsenal of resisting treatment, new research led by the Garvan Institute of Medical Research shows.

Chemotherapy 48

Chemotherapy 48

Pharmaceutical Technology

JULY 7, 2023

Shorla Oncology has signed a licensing agreement with an undisclosed drug UK firm for a chemotherapy drug, PIP-101.

Chemotherapy 52

Chemotherapy 52

Pharmaceutical Technology

JANUARY 4, 2024

ST-617 is under clinical development by Supportive Therapeutics and currently in Phase I for Chemotherapy Induced Oral Mucositis.

Chemotherapy 40

Chemotherapy 40

Pharma Mirror

MARCH 8, 2021

The post The drug Fenbendazole can make tumors sensitive to radiotherapy just like agents of chemotherapy appeared first on Pharma Mirror Magazine. 2] Presumably, fenbendazole multitherapy along with this little. 2] Presumably, fenbendazole multitherapy along with this little.

Chemotherapy 98

Chemotherapy 98

STAT

APRIL 10, 2024

These include oxytocin, which is used during childbirth; Rho(D) immune globulin, which helps some women during pregnancy; standard-of-care chemotherapy, pain and sedation medicines; and ADHD pills. Unresolved shortages have, in fact, been hovering above 300 for more than a year as numerous basic and life-saving medicines are in short supply.

Chemotherapy 285

Chemotherapy Immunity Immunization 285

Pharmacy Times

JULY 24, 2023

Treatment providers have been forced to adapt and make potentially life-altering decisions for patients due to persistent chemotherapy drug shortages, all while solutions from the FDA and drug manufacturers remain scant.

Chemotherapy 49

Chemotherapy 49

STAT

APRIL 11, 2024

Diagnosed at age 3 with acute myeloid leukemia, an aggressive blood cancer, Logan happened to have a targetable mutation that occurs in a small minority of childhood AML cases, making it possible for him to receive a precision therapy drug that — with chemotherapy — got him to a point where he could receive a bone marrow transplant.

Chemotherapy 320

Chemotherapy Hospitals 320

STAT

JANUARY 24, 2024

A year after an investigation revealed widespread use of a substandard cancer drug, the World Health Organization and national drug regulators around the world have come under fire for failing to protect children from the dangerous chemotherapy. The WHO plays a major role in protecting people worldwide from bad medicines.

Chemotherapy 331

Chemotherapy 331

Pharmacy Times

SEPTEMBER 2, 2022

DNA and RNA sequencing could provide insight about resistance to chemotherapy in patients suffering from triple-negative breast cancer.

Chemotherapy 62

Chemotherapy 62

STAT

MARCH 24, 2024

The latest entry is that of Catherine, the Princess of Wales, also known as Kate Middleton, who revealed she has cancer and is undergoing chemotherapy. As with her many of her predecessors, the princess’s story will likely both reveal and conceal, but I suspect it will ultimately both move and enlighten the public.

Chemotherapy 326

Chemotherapy 326

Med Ed 101

NOVEMBER 10, 2021

Chemotherapy-induced nausea and vomiting (CINV) is one of the most common side effects in patients getting treated for cancer. The post Chemotherapy-Induced Nausea and Vomiting Update appeared first on Med Ed 101. Prevention for CINV is important to improve quality of life and treatment outcomes.

Chemotherapy 40

Chemotherapy 40

STAT

OCTOBER 23, 2023

While the results assuaged some of the safety fears that flared when initial information was released over the summer, they only heightened concerns about the drug’s ability to outperform standard chemotherapy — though they perhaps pointed to an opportunity for the drug in a subset of patients.

Chemotherapy 248

Chemotherapy Drug Development 248

STAT

MAY 3, 2023

Immunogen released data from a trial comparing the new drug, Elahere, to traditional chemotherapy in 453 ovarian cancer patients who had already progressed on at least one other therapy and had a particular protein marker on their tumor. months for patients on chemotherapy. Patients who received Elahere lived a median of 16.46

Chemotherapy 235

Chemotherapy 235

STAT

JUNE 4, 2023

CHICAGO — An antibody that delivers chemotherapy directly to tumor cells extended the lives of women with a form of advanced ovarian cancer in a large study, researchers reported Sunday. months compared to just under 13 months for participants treated with standard chemotherapy. It was granted conditional approval in the U.S.

Chemotherapy 262

Chemotherapy 262

Pharmacy Times

MARCH 27, 2024

Benefits throughout post-progression endpoints and outcomes were reported for osimertinib in combination with chemotherapy.

Chemotherapy 20

Chemotherapy 20

STAT

SEPTEMBER 25, 2023

For months, oncologist Kristen Rice found herself scrambling for cisplatin and carboplatin, two key chemotherapies used for many different cancers including ovarian, bladder, and lung cancer. We went to put in our chemotherapy order, and our supplier said, ‘We don’t have any.’ “It came without warning.

Pharmacy Technician 289

Pharmacy Technician Chemotherapy Hospitals 289